[HTML][HTML] Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis

SG Franzblau, MA DeGroote, SH Cho, K Andries… - Tuberculosis, 2012 - Elsevier
In drug development, there are typically a series of preclinical studies that must be
completed with new compounds or regimens before use in humans. A sequence of in vitro …

Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: Anti–Mycobacterium tuberculosis activity and cytotoxicity

FR Pavan, PIS Maia, SRA Leite, VM Deflon… - European journal of …, 2010 - Elsevier
The aim of this study was to identify a candidate drug for the development of anti-
tuberculosis therapy from previously synthesized compounds based on the …

Schiff bases of indoline-2, 3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building

T Aboul-Fadl, FAS Bin-Jubair, O Aboul-Wafa - European journal of …, 2010 - Elsevier
Tuberculosis (TB) remains among the world's great public health challenges. Worldwide
resurgence of TB is due to two major problems: the AIDS epidemic, which started in the mid …

In vitro Anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis Strains

A Gemechu, M Giday, A Worku, G Ameni - BMC complementary and …, 2013 - Springer
Background Tuberculosis (TB) is a global burden with one–third of the world's population
infected with the pathogen Mycobacterium tuberculosis complex and annually 1.4 million …

Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence

N Andreu, T Fletcher, N Krishnan… - Journal of …, 2012 - academic.oup.com
Objectives Tuberculosis drug development is hampered by the slow growth of
Mycobacterium tuberculosis. Bioluminescence, light produced by an enzymatic reaction …

In vitro antibacterial activity of chitosan nanoparticles against Mycobacterium tuberculosis

G Wardani, SA Sudjarwo - Pharmacognosy journal, 2018 - phcogj.com
Background: Chitosan nanoparticles have gained growing interest for nanomedicine,
biomedical engineering and development of new therapeutic with improved bioavailability …

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery

A Speer, TB Shrestha, SH Bossmann… - Antimicrobial agents …, 2013 - Am Soc Microbiol
We and others recently identified copper resistance as important for virulence of
Mycobacterium tuberculosis. Here, we introduce a high-throughput screening assay for …

Natural compounds from Mexican medicinal plants as potential drug leads for anti-tuberculosis drugs

RC GóMez-CANsiNo, SL Guzmán-Gutiérrez… - Anais da Academia …, 2017 - SciELO Brasil
ABSTRACT In Mexican Traditional Medicine 187 plant species are used in the treatment of
respiratory conditions that may be associated with tuberculosis. In this contribution, we …

Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents

FR Pavan, G Von Poelhsitz, FB do Nascimento… - European Journal of …, 2010 - Elsevier
The synthesis, characterization and the anti-Mycobacterium tuberculosis (MTB) activities of
three ruthenium complexes containing the 2-pyridinecarboxylic acid anion (picolinate), with …

Evaluation of antimycobacterial, leishmanicidal and antibacterial activity of three medicinal orchids of Arunachal Pradesh, India

M Bhatnagar, N Sarkar, N Gandharv, O Apang… - … and Alternative Medicine, 2017 - Springer
Background The ethnic population of Arunachal Pradesh uses a number of orchids as such,
or in decoction for various ailments. Three untapped orchids namely, Rhynchostylis retusa …